SCHEMBL9237183

SCHEMBL9237183

CS(=O)(=O)OC1CCC([N+](=O)[O-])C(c2ccc(Cl)cc2Cl)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPK1 P28482 2/20 0.32
TSHR P16473 2/20 0.32
GAA P10253 2/20 0.31
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
LMNA P02545 1/20 0.31
CNR1 P21554 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9237968 0.83 MEN1 (0.35) MEN1KMT2A
SCHEMBL9237172 0.81 DPP4 (0.45) DPP4HTR2AHTR2CHTR2BMEN1
SCHEMBL9236818 0.79 HTR2A (0.40) DPP4HTR2AHTR2CHTR2BMEN1
SCHEMBL9242476 0.78 KMT2A (0.39) MEN1KMT2AALDH1A1KDM4EMAPK1
SCHEMBL8795487 0.75 CHRNB2 (0.38) MEN1KMT2AALDH1A1HPGD
SCHEMBL8977341 0.75 CHRNB2 (0.38) MEN1KMT2AALDH1A1HPGD
SCHEMBL9240648 0.74 PTGS2 (0.34) TSHRCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL3750791 0.70 DPP4 (0.34) DPP4HTR2AHTR2CHTR2BMEN1
SCHEMBL3750793 0.70 DPP4 (0.34) DPP4HTR2AHTR2CHTR2BMEN1
SCHEMBL3750797 0.70 DPP4 (0.34) DPP4HTR2AHTR2CHTR2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657455-A1 Epi-epibatidine derivatives, a process and intermediates for preparing them and epi-epibatidine and medicaments containing the epi-epibatidine derivatives and/or epi-epibatidine and the use of them EGIS GYOGYSZERGYAR (HU) 1995-06-14 EP disclosed